Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

NCT06549595

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Clovis, California, United States
View all 235 locations
View Trial Details
Recruiting

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

NCT06512883

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +14 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Cincinnati, Ohio, United States
  • Research Site Highland Hills, Ohio, United States
  • Research Site São Paulo, Brazil
View all 15 locations
View Trial Details
Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Rigshospitalet Copenhagen, Denmark
View all 25 locations
View Trial Details
Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610

Conditions
Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Saint-Herblain, France
  • Novartis Investigative Site Candiolo, TO, Italy
  • Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain
View Trial Details

Related conditions